“On one hand, people are excited that there’s just one shot [for Johnson & Johnson], and on the other, there’s a lot of confusion with regard to what the efficacy results actually say and does this mean it’s not as good,” Dr Andrasik, senior staff scientist for the Vaccine and Infectious Disease Division at Fred Hutch, told the BBC.
Click Here to Visit Orignal Source of Article https://www.bbc.co.uk/news/world-us-canada-56410179
